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Developmental Effects of Dioxins
Linda S. Birnbaum
Health Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park,
North Carolina
The potent developmental toxicity of dioxin in multiple species has been known for a number of years. However, recent studies have indicated that
dioxin also induces functional developmental defects, many of which are delayed. Subtle structural deficits, not detectable at birth, have also been
described in multiple species and in both sexes. Certain defects have been reported not only in animals but also in children prenatally exposed to
complex mixtures containing dioxinlike compounds. None of the effects can be attributed to modulation of any one endocrine system. For example,
dioxin does not bind to the estrogen receptor, but it can cause effects that are both estrogenic and antiestrogenic. However, viewing dioxin and
related compounds as endocrine disruptors that may alter multiple pathways sheds some light on the complexities of this potent class of growth
dysregulators. - Environ Health Perspect 103(Suppl 7):89-94 (1995)
Key words: TCDD, dioxins, developmental toxicity, growth dysregulation
Introduction
The dioxins represent a family of ubiqui-
tous environmental pollutants (1,2). The
prototype of this class of chemicals is
2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD, "dioxin"), which is often called
the most toxic man-made chemical. Other
polyhalogenated congeners with bromine
and/or chlorine in the four lateral posi-
tions also possess dioxinlike activity as do
structurally related members of the
polyhalogenated dibenzofurans, biphenyls,
napthalenes, and azo-, and azoxy-benzenes
(3). Of course, the majority of congeners
within these classes do not have dioxinlike
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activity but may display their own spec-
trum ofeffects (4).
Dioxin and related chemicals cause a
wide variety of responses ranging from
frankly adverse effects, such as lethality, to
biochemical changes, such as induction of
drug-metabolizing enzymes. There are sug-
gestions of sex and age differences in sus-
ceptibility to the lethal effects of dioxin,
but these parameters have not been care-
fully examined. However, it is clear that
the embryo/fetus of all species studied to
date display similar sensitivity to dioxin-
induced lethality. Death in the adult is
usually preceded by severe body-weight
loss known as the wasting syndrome.
Atrophy of the lymphoid tissue is a
consistent result of exposure to relatively
high doses of TCDD and related chemi-
cals. In addition, the gonads of the adult
display atrophy following high-dose expo-
sure. Testicular atrophy has been demon-
strated in rats (5), and recent studies have
shown ovarian atrophy in the same species
(K Rozman and A Cummings, personal
communications). While the effects in
these tissues may involve a hypoplastic
response, hyperplasia occurs in the liver,
gastric mucosa, and urinary tract. Changes
in both proliferation and differentiation in
the skin lead to chloracne, which is often
used diagnostically for high-level dioxin
poisoning. Alterations in cell proliferation
and differentiation may underlie the
immunotoxic, teratogenic, and carcinogenic
response to this class ofchemicals as well.
The biochemical effects ofdioxin can be
broken down into three types of responses
involving enzymes, growth factors, and
hormones. Induction ofdrug-metabolizing
enzymes alters the biotransformation
capacity and products of endogenous
compounds, such as steroids, and xenobi-
otics. Changes in the levels of enzymes
involved in proliferation and differentia-
tion, as well as various pathways ofinterme-
diary metabolism, alter the biochemical
state of the cell. Modulation of multiple
growth factors [e.g., epidermal growth fac-
tor (EGF), transforming growth factor ax
(TGFa), transforming growth factor f
(TGFI)] and their receptors (e.g., EGF
receptor), as well as cytokines (e.g., IL-113)
and protooncogene (e.g., c-fos, c-jun, c-ras)
expression, has also been demonstrated fol-
lowing dioxin exposure, which leads to
alterations in growth and differentiation.
Changes in both steroid and peptide
hormones have also been shown to result
from dioxin treatment. Levels of steroid
hormones such as androgens have been
shown to be lowered following dioxin expo-
sure, probably due to changes in steroid-
metabolizing enzymes (6). Estrogen
receptor levels are decreased following
dioxin exposure, although this is not a
particularly sensitive response except in
immature animals (7). Changes in the glu-
cocorticoid receptor appear to be tissue
specific. Thyroid hormones also appear to
respond to dioxin treatment, although the
response may be both dose and time depen-
dent. Melatonin levels in the blood appear
to decrease in response to TCDD (8). This
is intriguing in light of the sequence simi-
larity between the dioxin receptor and per
(9), a Drosophila gene involved in the con-
trol of circadian rhythms. Peptide hor-
mones (e.g., gastrin, insulin) and their
receptors are also altered by dioxin treat-
ment. Overall, dioxin modulation of hor-
mones and their receptors leads to altered
homeostasis. Viewing dioxin as an endo-
crine disruptor makes the tissue-specific,
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stage-specific, and time-specific nature ofits
effects more comprehensible.
The similarity ofdioxin to various hor-
mones is reinforced by the receptor-medi-
ated nature of dioxin's effects. For many
years it was hypothesized that the dioxin or
Ah (aryl hydrocarbon) receptor was a mem-
ber of the steroid-hormone superfamily of
receptors (10). However, it has recently
been shown to be the first ligand-activated
member of the helix-loop-helix family of
regulatory proteins (11,12) functioning as a
transcription factor (9). Most ofthe under-
standing of this mechanism comes from
intensive studies on the regulation of
CYPlAl (13,14). While a similar mecha-
nism appears to underlie dioxin-mediated
expression of CYP1A2 (15) and GSTYa
(16), there is little information on the
molecular nature of transcriptional control
ofother dioxin-responsive genes.
Recent studies have led to the sugges-
tion that the Ah receptor may function in
the cytoplasm as well as in the nucleus
(17,18). Increases in tyrosine phosphoryla-
tion appear to be a rapid and sensitive
response to dioxin exposure, both in vivo
(19-22) and in vitro (19,23,24). The pos-
sibility of two roles for the Ah receptor,
both as a transcriptional enhancer and as a
regulator of second messengers such as
tyrosine phosphorylation, appears to be
similar to what has been described for the
steroid hormones (25,26). Dioxin treat-
ment leads to biological amplification of
Ah receptor-mediated responses via a cas-
cade ofgrowth factors and hormones. The
use ofthe phrase "combinatorial complexity"
(27) seems mostappropriate.
Experimental Developmental
Toxicity
There have been several recent reviews on
the developmental toxicity of dioxin
and related compounds (28-30). Until
recently, it was believed that frank terata
were not detected in any species other than
mice except at doses that were overtly toxic
to the dam. However, at such doses,
decreased fetal growth and prenatal mortal-
ity were observed in rats, guinea pigs, ham-
sters, rabbits, and monkeys (31). Thymic
and splenic atrophy were observed in the
fetus in several species, and subcutaneous
edema was noted at higher doses in mouse
fetuses. Hemorrhage, both in the gastroin-
testinal tract and in the kidney, were
observed in rats and hamsters (32). Recent
studies from Walker et al. (33) have
demonstrated developmental toxicity in fish
as well, with dioxin inducing a syndrome
called blue-sac disease that occurs in the
swim-up stage offish.
Structural defects following dioxin
exposure have been reported in the mouse
at doses that do not cause either maternal
or fetal toxicity. The best described mal-
formation is cleft palate. There is a critical
window for the induction of this defect,
with peak incidence following exposure on
day 11 or 12 of gestation (31). In con-
trast, the induction of hydronephrosis
does not appear to have a peak window of
sensitivity during organogenesis and can
even be induced lactationally (34).
Hydronephrosis, however, is a more sensi-
tive response than cleft palate, being
induced at lower levels.
Both defects are due to altered differen-
tiation and proliferation of epithelial cells
in the respective tissues. The target for
dioxin's effect in the developing palate is
the medial edge epithelium. In normal
development, the medial edge cells trans-
form into mesenchyme (35) allowing
fusion of the opposing palatal shelves fol-
lowing contact toward the end of organo-
genesis. The medial peridermal cells slough
off the surface allowing the underlying
mesenchyme to fuse. Dioxin treatment
results in a failure of programmed cell
death of the peridermal cells. In addition,
the medial epithelium fails to transform
into mesenchyme. Instead, these cells con-
tinue to proliferate and develop into a
stratified, squamous, keratinizing epithe-
lium with desmosomes and tonofilaments
(36,37). The opposing shelves make con-
tact, but fusion is impossible because ofthe
intact epithelium. The altered proliferation
and differentiation is accompanied by
changes in the balance of various growth
factors and receptors. For example, in the
mouse, TCDD treatment both in vivo
(38-40) and in vitro (39) results in ele-
vated levels of the EGF receptor and
TGFO. Recent studies have demonstrated
that exposure of the pregnant mouse to
dioxin results in increased expression ofthe
glucocorticoid receptor in the developing
palate (41). Similar growth factor effects
have been noted in vitro with exposure of
embryonic human palates to TCDD
(42-44). The Ah receptor has also been
detected in the developing palate in both
mouse and human tissue (44,45). In the
palatal epithelium, this receptor is both
nuclear and cytosolic. Exposure to TCDD,
in vivo in the mouse and in vitro in the
human palate, results in altered expression
of the Ah receptor both in the epithelium
and in the mesenchyme.
Dioxin-induced hydronephrosis is due
to hyperplasia of the ureteric epithelium,
leading to blockage of the ureteric lumen.
Once the fetus begins to produce urine, the
back pressure builds up due to blockage of
urine outflow, and destruction ofthe renal
parenchyma results (46). TCDD treat-
ment results in elevated levels of EGF
receptor in the ureteric epithelium (47),
similar to what has been observed in the
palatal epithelium (39,44). There is a pos-
sibility that dioxin also has direct effects
on the developing kidney. Abbott and
coworkers (48) noted effects on the
extracellular matrix surrounding the
Bowman's capsule; there was a decrease in
both laminin and type IV collagen. Such a
change could lead to a decrease in the
functional integrity of the glomerulus and
alteration ofthe normal filtration barrier.
The endocrine-disrupting nature of
dioxin can be seen not only in the altered
expression of growth factors and receptors
in target tissues such as the palate and
ureteric epithelium, but it also can be seen
in the synergistic interactions demonstrated
with other growth factors and hormones.
Treatment with either triiodothyronine
(T3) or thyroxine (T4) appears to potenti-
ate the induction of cleft palate in the
mouse (49). Retinoic acid, the physiologic
active form of vitamin A, interacts syner-
gistically with dioxin to induce cleft palate
(38,39,50,51). These interactions are, how-
ever, tissue specific since retinoic acid does
not have any effect on the induction of
dioxin-induced hydronephrosis. A synergis-
tic interaction ofdioxin and hydrocortisone
in the induction of cleft palate was noted
several years ago (52). Recently, the basis
for this interaction has been investigated
(41) and appears to involve a feedback loop
in which dioxin increases the levels ofglu-
cocorticoid receptor in the palate and
hydrocortisone elevates the amount ofAh
receptor. Blankenship et al. (53) have also
shown that TCDD inappropriately acceler-
ates differentiation in the earlyembryo.
Much of the recent interest in the
developmental effects ofdioxin and related
compounds has stemmed from the studies
conducted at the University of Wisconsin
by Peterson and co-workers. In a series
of studies (54-56), these investigators
reported on the effects of prenatal expo-
sure on male rat reproductive parameters.
Basically, towards the end oforganogenesis
(gestation day 15), they exposed the preg-
nant Holtzman rat to low levels of dioxin
and conducted functional assessments of
male pups from birth through adulthood.
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They reported decreases in the anogenital
distance, accessory sex organ weights, and
spermatogenesis at doses as low as 64 ng
TCDD/kg body weight of the mother on
GD15. In addition, they reported that the
sexual behavior of the male offspring was
both demasculinized and feminized and the
regulatin of LH secretion was feminized.
They have not been able to repeat some of
their published observations on effects on
circulating male hormone levels (57).
Studies from our laboratory have
attempted to confirm and extend the
findings of Peterson and coworkers. Using
an experimental paradigm based on that of
Mabley et al. (54-56), Gray et al. (58,59)
treated pregnant Long-Evans rats on
GD15 with 1 pg TCDD/kg body weight
and examined both the male and female
offspring at birth, puberty, and adulthood.
A small number ofHoltzman rats were also
included in this study. In addition, preg-
nant Syrian golden hamsters were exposed
on GD11, a comparable developmental
stage to GD15 in the rat, with 2 pg
TCDD/kg. As noted earlier by Mabley et
al. (54), anogenital distance was reduced in
the male rat pup at birth. However, the
amount of reduction was less in the
Long-Evans rat than in the Holtzman rat,
and there was no effect on anogenital dis-
tance in the neonatal hamster (59). Serum
testosterone levels were normal in the new-
born rat in contrast to the original report
of Mabley (54), but consistent with later
publications from the same laboratory
(57). In vitro testosterone production was
also unaffected, not only just after birth
but at puberty (59). In fact, puberty was
delayed in both the male rat and hamster
following prenatal and lactational exposure
to dioxin as measured by a delay in
preputial separation. Body weight was
slightly (6%) but significantly decreased in
the male pups at puberty.
Effects on sperm numbers were noted
at puberty in rats and persisted throughout
adulthood into at least middle age.
Testicular sperm production was down
30% at puberty, but in adulthood was
down only 5%. This was accompanied by a
slight (5%) drop in testis weight at
puberty. Serum testosterone levels were
normal, but ventral prostate and seminal
vesicle weights were reduced. Epididymal
sperm counts were decreased 59% at
puberty and were still down 30% at adult-
hood. Ejaculated sperm counts, measured
by mating to satiety and collection ofsperm
from the female partners, were down 60%
in both rats and hamsters prenatally and
lactationally exposed to TCDD. No reduc-
tion in androgen receptor numbers were
found in the seminal vesicle, ventral
prostate, and epididymis. There were subtle
alterations in male sexual behavior, similar
to that previously observed by Mabley et al.
(55). Gray et al. (59) observed no differ-
ence in latency to mount, but more mounts
were necessary for ejaculation. Given the
adverse effects of dioxin on the develop-
ment of the urogenital tract, this altered
male sexual behavior maywell have a physi-
cal basis. No effect on female sex behavior
(lordosis) in the castrated male Long-Evans
rats was noted, in contrast to the results
reported in the Holtzman rat (55). This
could reflect a strain difference in lordotic
tendencies. There was no difference in sex
behavior in the male hamster offspring.
Reproductive alterations in the female
offspring following prenatal and lactational
exposure involved structural malformations
in the urogenital tract (58). In both rats and
hamsters, cleft phallus and hypospadias were
present. Minimal to severe clefting of the
phallus/clitoris was observed in the majority
of female offspring. Hypospadias accompa-
nied the severe clefting. Vaginal opening
was incomplete and accompanied by a per-
sistent thread of tissue across the vaginal
orifice in many of the female rat pups.
Vaginal openingwas delayed in the hamster,
who also evidenced an abnormal vaginal
estrus. Litter sizes were reduced in the female
hamsters following the prenatal and lacta-
tional dioxin exposure at 2 pg TCDD/kg. It
is interesting to note that the combination of
phallic clefting and hypospadias has also
been observed in female offspring of
DES-treated female rats (60).
The reported alterations in male sexual
behavior, demasculinization and feminiza-
tion, led to examination ofsexually dimor-
phic behaviors in middle-aged male rat
offspring following prenatal and lactational
exposures to TCDD (D Miller, personal
communication). Using the same paradigm
(exposure on GD15 to 1 pg TCDD/kg in
Long-Evans rats), there was no effect on
motor activity in the male offspring.
Females generally exhibit more rearing
behavior than males, and TCDD caused
no increase in this behavior in the male
pups. Learning and memory also show sex-
ual dimorphism. Spatial learning is usually
greater in males than in females. No effects
were seen using the Morris water maze,
which examines this endpoint. Likewise,
saccharin preference shows a male/female
difference and was also unaffected by pre-
natal/lactational exposure. Recent studies
also fail to report any change in the size of
the sexually dimorphic nuclei in the hypo-
thalamus (61). Thus, there is little evi-
dence at this time for a direct impairment
of the central nervous system following
prenatal and lactational TCDD exposure.
Effects of this exposure paradigm were
also examined for nonsexually dimorphic
responses. Changes in glial fibrially acidic
protein (GFAP) are often considered a
marker of neurotoxicity (62). Miller and
O'Callaghan (personal communication)
failed to detect any changes in GFAP levels
following prenatal and lactational TCDD
exposure. However, the core body temper-
ature appears to be permanently reduced in
these rats, suggesting a downward shift in
the set point for the control of body tem-
perature (C Gordon, personal communica-
tion). This lowered body temperature,
which persists until at least 18 months of
age, occurs in the absence of any effect on
metabolic rate. These adult male rats
whose mothers were exposed to only 1 pg
TCDD/kg on GD15 weigh 10% less than
matched controls throughout their lives.
Few laboratory studies have been con-
ducted on the functional developmental
toxicity of compounds related to TCDD.
However, Lundkvist (63) did examine the
effects ofprenatal and lactational exposure
to a complex PCB mixture, Clophen A50,
in guinea pigs. Similar to many of the
results observed in rats and hamsters, there
was a delay in sexual maturation in both
male and female offspring. Vaginal open-
ing was delayed in females, and there was a
decrease in testis weight in the males. Some
growth retardation was noted. Similar to
the results ofGray et al. (59), there was no
difference in plasma testosterone levels.
Thus, studies in rats, hamsters, and guinea
pigs all suggest a direct effect ofdioxin and
related compounds on the developing geni-
tourinary tract. This would be compatible
with the direct effect of dioxin on the
ureteric epithelium, which is part of the
genitourinary tract. Whether these effects
are induced by late prenatal exposure or
early postnatal lactational exposure is not
fully resolved. It is clear that exposure late
in organogenesis is more effective at induc-
ing these effects than exposure earlier in
gestation; exposure ofrats on GD8 resulted
in the same spectrum ofresponses but at a
lower incidence and severity than following
exposure on GD15 (59). However, Bjerke
and Peterson (64) have conducted cross-
fostering studies in the rat which indicate
that the majority of these effects are
induced by exposure before birth. It is
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important to note that developmentally in
many tissues the neonatal rodent is similar
to a second- or third-trimester human fetus.
Functional developmental toxicity of
TCDD has also been noted in the immune
system. Atrophy of the fetal thymus has
long been known following prenatal dioxin
exposure in many species. Exposure ofthe
pregnant mouse to TCDD towards the
end of organogenesis (GD14) resulted in
altered maturation oflymphocytes (65,66)
and changes in the differentiation of T
lymphocytes (67) at doses below that
where thymic atrophy occurs. Analysis of
thymic lymphocytes by flow cytometry
demonstrated that prenatal exposure tar-
geted immature CD3- cells in the both the
Long-Evans and the Fisher rat (68). There
were increases in the relative amount of
CD4-CD8- and CD4-CD8+ cells and a
decrease in the percentage of CD4+CD8+
thymocytes, suggesting that TCDD acts on
the CD3-CD4+CD8+ population of
immature cells in the fetal thymus. This
suggests a decrease in thymic cellularity
and a decrease in splenic T cells. The
implications of an elevated percentage of
maturing cytoxic/suppressor T cells is
unclear. The persistence of these effects is
currently under study.
Developmental Toxicity
in People
The developmental effects of dioxins in
humans are much less clear than in the rat
and mouse. There have been no in-depth
epidemiological studies ofchildren born to
women exposed to TCDD. (In fact, there
have been few studies conducted of
TCDD-exposed women at all; most ofthe
studies have involved adult men). A recent
report from the Netherlands examined the
levels of circulating thyroid hormone in
children and found an increase in T4
levels associated with higher levels of
PCDDs/PCDFs in their mother's breast
milk (69). Children born to women
exposed in the 1976 poisoning in Seveso,
Italy, have no increase in obvious birth
defects (70). However, there has not been
a follow-up of that cohort to determine if
functional developmental toxicity is pre-
sent. In contrast, clear evidence ofdevelop-
mental toxicity has been found in two
cohorts inadvertently exposed to complex
mixtures ofPCBs and PCDFs. In both the
Yusho and Yu-Cheng poisonings in Japan
and Taiwan, respectively, there was a
increased incidence of stillbirths born to
exposed women (71). The Yu-Cheng
cohort continues to be intensively followed
(72). The developmental delays present in
the infants have persisted, with children
now between the ages of8 and 13 years of
age evidencing behavioral problems (73),
intellectual deficits (74), and growth retar-
dation (75). While the ectodermal dyspla-
sia syndrome (76) noted at birth has
tended to resolve, other functional impair-
ments have been noted; for example, the
children appear to have hearing loss (77).
A recent report has raised the concern
about reproductive alterations; the boys
appear to have significantly smaller penises
when they reach puberty than matched
controls (78). There is also a suggestion of
immunosuppressive effects of the prenatal
exposure to the PCB/PCDF mixtures, as
the children have elevated incidences of
respiratory infections and otitis (76).
These findings are compatible with the
recent report of immunological effects in
children born to women with high PCB
levels in their breast milk in Arctic Quebec
(79). A preliminary report on this popula-
tion suggested changes in T-cell subsets in
the prenatally exposed infants.
Conclusions
Dioxin's developmental effects, both struc-
tural and functional, immediate and
delayed, are complex and tend to resemble
those seen with effects on multiple hor-
mone systems. Recent studies have sug-
gested that dioxin is an antiestrogen (80)
because of its ability to block proliferation
of the uterine lining in response to estro-
gen in the immature rodent and its ability
to block estrogen response in breast cancer
cell lines. However, dioxin is not an
antiestrogen in the classical sense ofblock-
ing estrogen binding to the estrogen recep-
tor. It may alter the metabolism of
estrogen, potentially leading to a decrease
in the active form ofthe hormone at target
sites. It also leads to decreased numbers of
estrogen receptors. Dioxin is also not an
estrogen and does not bind to the estrogen
receptor. It does not cause classical estro-
genic responses, but some of the effects of
dioxin do resemble those seen with potent
synthetic estrogens such as DES. Estrogen
appears to be necessary for dioxin to cause
cancer in rat liver (81), and recent studies
suggest that it may be necessary to allow
the progression of TCDD-promoted
endometriosis in mice (A Cummings,
personal communication).
The appropriate way to view dioxin is
as a modulator of growth and develop-
ment. Depending on the tissue and stage of
development, dioxin may be estrogenic or
antiestrogenic. Its effects may resemble
those of hypovitaminosis or hypervita-
minosis A. Dioxin can cause either sup-
pression or elevation of circulating
thyroxin levels. It causes hypoplasia, hyper-
plasia, and metaplasia, as well as neoplasia.
Dioxin increases the amounts ofTGFa in
some tissues and decreases it in others. The
same can be said ofboth the glucocorticoid
and the EGF receptors-down regulation
versus enhanced expression-depending
on the cell, tissue, and stage of develop-
ment. Dioxin appears to perturb normal
homeostasis and hormonal balance leading
to alterations in proliferation and differen-
tiation. In the adult, such changes may lead
to cancer, immunosuppression, chloracne,
and endometriosis. In the embryo/fetus,
altered programming of developing tissues
leads both to overt malformations, anom-
alies, fetal toxicity, and functional and
structural deficits, which are often not
detectable until later in life. Whether the
multiple functional and subtle structural
deficits detected at low levels of dioxin
exposure in prenatally exposed experimen-
tal animals are occurring in the human
population remains to be determined.
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